SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-008787
Filing Date
2024-01-31
Accepted
2024-01-31 16:05:16
Documents
14
Period of Report
2024-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244678d1_8k.htm   iXBRL 8-K 37708
  Complete submission text file 0001104659-24-008787.txt   214087

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20240131.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20240131_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20240131_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm244678d1_8k_htm.xml XML 3616
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 24582888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)